Cost-effectiveness of provider-based HIV partner notification in urban Malawi

被引:44
|
作者
Rutstein, Sarah E. [1 ]
Brown, Lillian B. [2 ,3 ]
Biddle, Andrea K. [1 ]
Wheeler, Stephanie B. [1 ]
Kamanga, Gift [4 ]
Mmodzi, Pearson [4 ]
Nyirenda, Naomi [4 ]
Mofolo, Innocent [4 ]
Rosenberg, Nora E. [2 ]
Hoffman, Irving F. [3 ]
Miller, William C. [2 ,3 ]
机构
[1] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27599 USA
[4] UNC Project, Lilongwe, Malawi
基金
美国国家卫生研究院;
关键词
Cost-benefit analysis; contact tracing; HIV; sub-Saharan Africa; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; DISCORDANT COUPLES; REFERRAL SERVICES; RISK BEHAVIORS; COITAL-ACT; INFECTION;
D O I
10.1093/heapol/czs140
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Provider-initiated partner notification for HIV effectively identifies new cases of HIV in sub-Saharan Africa, but is not widely implemented. Our objective was to determine whether provider-based HIV partner notification strategies are cost-effective for preventing HIV transmission compared with passive referral. We conducted a cost-effectiveness analysis using a decision-analytic model from the health system perspective during a 1-year period. Costs and outcomes of all strategies were estimated with a decision-tree model. The study setting was an urban sexually transmitted infection clinic in Lilongwe, Malawi, using a hypothetical cohort of 5000 sex partners of 3500 HIV-positive index cases. We evaluated three partner notification strategies: provider notification (provider attempts to notify indexes' locatable partners), contract notification (index given 1 week to notify partners then provider attempts notification) and passive referral (index is encouraged to notify partners, standard of care). Our main outcomes included cost (US dollars) per transmission averted, cost per new case identified and cost per partner tested. Based on estimated transmissions in a 5000-person cohort, provider and contract notification averted 27.9 and 27.5 new infections, respectively, compared with passive referral. The incremental cost-effectiveness ratio (ICER) was $3560 per HIV transmission averted for contract notification compared with passive referral. Provider notification was more expensive and slightly more effective than contract notification, yielding an ICER of $51 421 per transmission averted. ICERs were sensitive to the proportion of partners not contacted, but likely HIV positive and the probability of transmission if not on antiretroviral therapy. The costs per new case identified were $36 (provider), $18 (contract) and $8 (passive). The costs per partner tested were $19 (provider), $9 (contract) and $4 (passive). We conclude that, in this population, provider-based notification strategies are potentially cost-effective for identifying new cases of HIV. These strategies offer a simple, effective and easily implementable opportunity to control HIV transmission.
引用
收藏
页码:115 / 126
页数:12
相关论文
共 50 条
  • [41] Cost-effectiveness of early identification of HIV infection
    Nichols, Brooke E.
    Meyer-Rath, Gesine
    LANCET HIV, 2017, 4 (10): : E431 - E432
  • [42] The Cost and Cost-Effectiveness of Expedited Partner Therapy Compared With Standard Partner Referral for the Treatment of Chlamydia or Gonorrhea
    Gift, Thomas L.
    Kissinger, Patricia
    Mohammed, Hamish
    Leichliter, Jami S.
    Hogben, Matthew
    Golden, Matthew R.
    SEXUALLY TRANSMITTED DISEASES, 2011, 38 (11) : 1067 - 1073
  • [43] HIV transmission and the cost-effectiveness of methadone maintenance
    Zaric, GS
    Barnett, PG
    Brandeau, ML
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (07) : 1100 - 1111
  • [44] MODELLING THE COST-EFFECTIVENESS OF HIV PREVENTION INTERVENTIONS
    Hallett, Tim
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A6 - A7
  • [45] HIV prevention cost-effectiveness: a systematic review
    Galarraga, Omar
    Arantxa Colchero, M.
    Wamai, Richard G.
    Bertozzi, Stefano M.
    BMC PUBLIC HEALTH, 2009, 9
  • [46] Comparing the cost-effectiveness of HIV prevention interventions
    Cohen, DA
    Wu, SY
    Farley, TA
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (03) : 1404 - 1414
  • [47] HIV prevention cost-effectiveness: a systematic review
    Omar Galárraga
    M Arantxa Colchero
    Richard G Wamai
    Stefano M Bertozzi
    BMC Public Health, 9
  • [48] Cost-effectiveness of voluntary HIV screening in Russia
    Tole, S. P.
    Sanders, G. D.
    Bayoumi, A. M.
    Galvin, C. M.
    Vinichenko, T. N.
    Brandeau, M. L.
    Owens, D. K.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2009, 20 (01) : 46 - 51
  • [49] Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention
    Enns, E. A.
    Brandeau, M. L.
    Igeme, T. K.
    Bendavid, E.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (10) : 558 - 567
  • [50] The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi
    Chinkhumba, Jobiba
    De Allegri, Manuela
    Brenner, Stephan
    Muula, Adamson
    Robberstad, Bjarne
    BMJ GLOBAL HEALTH, 2020, 5 (05):